These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The microbiological faultlessness of drugs. III. Development and problems of testing methods]. Sagáth J; Chalabala M; Bábik I Cesk Farm; 1978 Oct; 27(8):353-8. PubMed ID: 743754 [No Abstract] [Full Text] [Related]
8. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms. Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952 [TBL] [Abstract][Full Text] [Related]
10. [Validation of demineralized water plants through total microbial count and definition of a microbiological standard]. Anastasio P; Burinato C; Carazzone M; Ferioli S; Genova R; Malesani L; Molinari ML; Veronese M Boll Chim Farm; 1985 Jun; 124(6):259-70. PubMed ID: 4063093 [No Abstract] [Full Text] [Related]
13. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients. Subert J; Cizmárik J Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414 [TBL] [Abstract][Full Text] [Related]
14. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report. World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961 [No Abstract] [Full Text] [Related]
16. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report. World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103 [No Abstract] [Full Text] [Related]
17. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
18. [Microbiological in-process control in drug manufacture]. Seyfarth VH Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162 [TBL] [Abstract][Full Text] [Related]
19. [For a strict quality of active pharmaceutical ingredients]. Astier A Ann Pharm Fr; 2008 Mar; 66(2):69-70. PubMed ID: 18570901 [No Abstract] [Full Text] [Related]
20. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related] [Next] [New Search]